The current research & development by business enterprise, pharmaceutical industry in local currency in Norway is 466.09 million, which has increased by 23.39 million (5.3%) since 2020.
Research & development by business enterprise, pharmaceutical industry in local currency in Norway
No matching regions
Similar regions to Norway
Business R&D pharmaceutical in local currency
More indicators for Norway
Government R&D in security as % of government support
2.91%
+0.22%
(2021)
Higher-education-finacing R&D financed by general university in local currency
184,346.70M
+6,664.70M
(2021)
R&D financed by rest of the world in local currency
65,896.14M
+4,998.14M
(2021)
Government R&D financed by rest of the world in local currency
6,078.91M
+222.91M
(2021)
Business R&D financed by rest of the world in local currency
48,835.97M
+3,672.97M
(2021)
Non-profit R&D growth rate
-100%
-120.34%
(2022)
Norway Business R&D pharmaceutical in local currency between 1987 and 2021
| Period | Business R&D pharmaceutical in local currency | Change |
|---|---|---|
| 2021 | 466.09M | +23.39M |
| 2020 | 442.70M | +12.50M |
| 2019 | 430.20M | +1.50M |
| 2018 | 428.70M | +23.80M |
| 2017 | 404.90M | +48.80M |
| 2016 | 356.10M | +25.90M |
| 2015 | 330.20M | -11.30M |
| 2014 | 341.50M | -42.10M |
| 2013 | 383.60M | -8.20M |
| 2012 | 391.80M | -328.70M |
| 2011 | 720.50M | +228.10M |
| 2010 | 492.40M | +35.70M |
| 2009 | 456.70M | -40.20M |
| 2008 | 496.90M | -0.10M |
| 2007 | 497.00M | +32.88M |
| 2006 | 464.12M | -5.28M |
| 2005 | 469.40M | -49.10M |
| 2004 | 518.50M | +92.60M |
| 2003 | 425.90M | +41.48M |
| 2002 | 384.42M | -47.08M |
| 2001 | 431.50M | -87.56M |
| 2000 | 519.06M | -25.94M |
| 1999 | 545.00M | +103.68M |
| 1998 | 441.32M | +111.02M |
| 1997 | 330.30M | -5.85M |
| 1996 | 336.15M | -64.25M |
| 1995 | 400.40M | -44.20M |
| 1993 | 444.60M | +13.33M |
| 1992 | 431.27M | +24.07M |
| 1991 | 407.20M | +30.32M |
| 1990 | 376.88M | +44.78M |
| 1989 | 332.10M | +66.59M |
| 1988 | 265.51M | +79.51M |
| 1987 | 186.00M |